Vivozon Pharmaceutical’s Chairman Lee Doo-hyun, whose company is developing non-narcotic painkiller opiranserin (VVZ-149), has issued a strongly worded statement to its shareholders and employees.Last Wednesday, the company posted a statement on its website last month in the name of Chairman Lee."Fo
Daewoong Pharmaceutical said on Sunday that it applied to the Ministry of Food and Drug Safety (MFDS) for a long-term phase 3 clinical trial to demonstrate the long-term safety and efficacy of Envlo (ingredient: enavogliflozin) 0.3-milligram tablets in combination with gemigliptin and metformin, for
Numeco, an affiliate of the botulinum toxin (BTX) maker Medytox, said the Ministry of Food and Drug Safety has approved Newlux, a next-generation BTX product.Newlux, Numeco's first BTX preparation, is a next-generation toxin preparation in a freeze-dried powder formulation.The BTX is characterized b
AVEO Pharmaceuticals, a subsidiary of LG Chem, has completed the U.S. phase 2 clinical trial of ficlatuzumab, a head and neck cancer candidate, and published the results in an international journal.As the LG Group has recently shown its commitment to developing new drugs, LG Chem's plans are drawing
Huons said it has recently renewed its agreement with Biosyn Korea, the Korean offshoot of Biosyn Arzneimittel GmbH, a German pharmaceutical company, for the exclusive domestic distribution rights of Selenase, a selenium deficiency treatment.This agreement is an extension of the existing exclusive d
Hugel said it has resubmitted its new drug application (NDA) to the U.S. Food and Drug Administration (FDA) for 50 and 100 units of Letybo (brand name in Korea: Botulax), its botulinum toxin (BTX) preparation.The NDA is the third challenge after the company received supplemental requests for the las
QuantaMatrix, an in vitro diagnostics company, said on Thursday that it won a tender valued at €11 million ($15.4 billion) to exclusively supply its direct & Rapid Antimicrobial Susceptibility Test (dRAST) for four years to public hospitals in France. QuantaMatrix was selected by Union des Hôpitaux
Vyvgart (efgartigimod), a breakthrough treatment for generalized myasthenia gravis (gMG), will be introduced in Korea.Handok said Wednesday it would strengthen the rare disease business by introducing Vyvgart, a new treatment for gMG. Handok has signed an agreement with argenx BV to handle the licen
JW Pharmaceutical said Wednesday that a study demonstrating the effectiveness and safety of Hemlibra (emicizumab), a treatment for hemophilia A, in Korean patients, was recently published in the international journal Haemophilia.This is the first time that real-world data evaluating the efficacy and
Yuhan Corp.'s Leclaza (ingredient: lazertinib) has passed the Cancer Drugs Benefit Appraisal Committee, the first gateway to expanded reimbursement as a first-line treatment for patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) with an epidermal growth factor receptor (
Takeda Korea said it has begun replacing Baxject II reconstitution devices for hemophilia A treatment Advate Inj. and hemophilia B treatment Rixubis Inj. after finding plastic inside some of the devices.According to the Ministry of Food and Drug Safety (MFDS), the matter came to light after Takeda K
Coreline Soft said on Wednesday that it entered into a strategic partnership with HealthCare Konnect (HCK), a specialized Swiss medical device distributor, to expand its suite of AVIEW AI-based solutions into the Swiss market.HCK provides professional consulting and resources to help hospitals and p
AriBio said Tuesday the Ministry of Food and Drug Safety (MFDS) has approved a multi-country phase 3 clinical trial of AR1001, an investigational tablet to treat early Alzheimer’s disease.With the approval, the company plans to conduct the study in 150 patients with Samjin Pharmaceutical in Korea. I
The U.S. Patent Trial and Appeal Board (PTAB) issued an order on Aug. 22 denying Hugel’s petition against Medytox to invalidate the latter’s U.S. patent on botulinum toxin (BTX).This resurfaces the complaint filed by Hugel with the PTAB on Feb. 21, claiming that Medytox's patent (U.S. patent number:
Voronoi said Monday that the company would step up its open innovation business by developing new drugs based on AI.Market watchers interpreted it as a strategy to discover candidates for other companies by utilizing AI drug development platforms and generating profits."Through technology transfer a
Hancom Carelink, a company specializing in genomic analysis and digital healthcare, said on Tuesday that it has been selected by the Korea Disease Control and Prevention Agency (KDCA) to conduct a project that evaluates the health effects of air pollution.Engaging in the project, the company will co
Huons said on Tuesday that it will expand its free support for the continuous glucose monitor (CGM), Dexcom G6, for diabetic patients to help them reduce the burden of medical expenses.This is the second time that the company has tried to alleviate the medical cost burden for patients. In June 2021,
JW Pharmaceutical said Monday that JW0061, a Wnt-targeted hair loss treatment, has been selected as a project for the “first national new drug development project in 2023.”The company also signed a research and development (R&D) agreement with the Korea Drug Development Fund (KDDF).Under the agreeme
LG Group, a Korean conglomerate operating a wide range of business including electronics, chemicals, and telecommunications, has announced an intention to expand its bio business globally as a future growth engine.Group Chairman Koo Kwang-mo, while reaffirming his will to develop innovative new drug
Celltrion and Celltrion Healthcare held a board meeting on Monday and decided to repurchase shares to stabilize stock prices to enhance shareholder value and increase confidence in business growth.Celltrion will repurchase a total of 696,865 shares of its own stock for an aggregate purchase price of